Evidence map›Paper›PMID 34438767›Full record

ArticleAnimals : an open access journal from MDPI2021

Effect of GP19 Peptide Hyperimmune Antiserum on Activated Macrophage during

Boondarika Nambooppha, Amarin Rittipornlertrak, Anucha Muenthaisong, Pongpisid Koonyosying, Sahatchai Tangtrongsup, Saruda Tiwananthagorn, Yang-Tsung Chung, Nattawooti Sthitmatee

Abstract read
In one paragraph

Article in Animals : an open access journal from MDPI, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Mitochondrial Dysfunction inTransboundary and emerging diseases · 2026
    Review
  3. Veterinary sciences · 2024
    Review
  4. RecombinantVeterinary sciences · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Boondarika NamboopphaDepartment of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.ORCID 0000-0002-9951-9915
Amarin RittipornlertrakDepartment of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.
Anucha MuenthaisongDepartment of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.
Pongpisid KoonyosyingDepartment of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.
Sahatchai TangtrongsupDepartment of Companion Animals and Wildlife Clinics, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.ORCID 0000-0001-9417-7736
Saruda TiwananthagornDepartment of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.ORCID 0000-0002-9066-7137
Yang-Tsung ChungDepartment of Veterinary Medicine, College of Veterinary Medicine, National Chung Hsing University, Taichung 402, Taiwan.
Nattawooti SthitmateeDepartment of Veterinary Biosciences and Veterinary Public Health, Faculty of Veterinary Medicine, Chiang Mai University, Chiang Mai 50100, Thailand.ORCID 0000-0002-2329-8802

Funding

Chiang Mai University 012/2562Thailand Research Fund PHD58I0063
6 · The paper itself

Abstract

In terms of its veterinary importance, vaccine development against

Indexed as

cytokineDH82Ehrlichia canisGP19hyperimmunemacrophage-like cellspeptide

Identifiers

PMID34438767
PMCPMC8388390

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.